SCHEMBL28629514

SCHEMBL28629514

CC(C)(C)OC(=O)N(C(=N)N)S(=O)(=O)C(F)(F)F

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CA14 Q9ULX7 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2836502 0.78
SCHEMBL5574662 0.78 CA14 (0.34) CA14
Trifluoromethanesulfonic Acid SCHEMBL2352815 0.78 CA14 (0.32) CA14
SCHEMBL28296147 0.75 CA14 (0.37) CA14
SCHEMBL1259595 0.74 HDAC6 (0.34) CA14
SCHEMBL28705195 0.69 HDAC6 (0.33) CA14
SCHEMBL22143232 0.69 HDAC6 (0.33) CA14
SCHEMBL5121775 0.68 DGAT1 (0.36) CA14
SCHEMBL3996593 0.68 CA12 (0.33) CA14
SCHEMBL7856537 0.67 HDAC6 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024234082-A1 GUANIDINYLATED AMPHIPHILIC TOBRAMYCIN DERIVATIVES AND B-LACTAM/B-LACTAMASE INHIBITOR COMBINATIONS FOR TREATMENT OF PSEUDOMONAS AERUGINOSA INFECTIONS UNIVERSITY OF MANITOBA (CA) 2024-11-21 WO disclosed
CN-109111376-B 2, 5-dideoxy streptomycin derivative and application thereof 四川医立特生物医药有限公司 2021-09-14 CN disclosed